CADL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CADL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Candel Therapeutics's inventories, raw materials & components for the quarter that ended in Sep. 2024 was $0.00 Mil.
The historical data trend for Candel Therapeutics's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Candel Therapeutics Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Inventories, Raw Materials & Components | - | - | - | - | - |
Candel Therapeutics Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Inventories, Raw Materials & Components | Get a 7-Day Free Trial | - | - | - | - | - |
Materials and components scheduled for use in making a product.
William Garrett Nichols | officer: Chief Medical Officer | C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST SUITE 450, NEEDHAM MA 02494 |
Paul Peter Tak | director, officer: President & CEO | CANDEL THERAPEUTICS, INC., 117 KENDRICK ST SUITE 450, NEEDHAM MA 02494 |
Francesca Barone | officer: Chief Scientific Officer | CANDEL THERAPEUTICS, INC., 117 KENDRICK ST SUITE 450, NEEDHAM MA 02494 |
Seshu Tyagarajan | officer: See Remarks | CANDEL THERAPEUTICS, INC., 117 KENDRICK ST SUITE 450, NEEDHAM MA 02494 |
Estuardo Aguilar-cordova | director, officer: Chief Scientific Officer | CANDEL THERAPEUTICS, INC., 117 KENDRICK ST SUITE 450, NEEDHAM MA 02494 |
Nicoletta Loggia | director | CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM MA 02494 |
Jason Amello | officer: Chief Financial Officer | 500 KENDALL STREET, CAMBRIDGE MA 01824 |
Christopher Martell | director | CANDEL THERAPEUTICS, INC., 117 KENDRICK ST SUITE 450, NEEDHAM MA 02494 |
Joseph C Papa | director | C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807 |
Gary J. Nabel | director | C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065 |
Renee Gaeta | director | C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958 |
Diem Nguyen | director | C/O VERRICA PHARMACEUTICALS INC., 10 NORTH HIGH STREET, SUITE 200, WEST CHESTER PA 19380 |
Nathan Caffo | officer: Chief Business Officer | C/O ALX ONCOLOGY HOLDINGS INC., 866 MALCOLM ROAD, SUITE 100, BURLINGAME CA 94010 |
Paul B Manning | director | 200 GARRETT STREET SUITE S, CHARLOTTESVILLE VA 22902 |
John J Canepa | officer: Chief Financial Officer | 241 MATTINSON DRIVE, CONCORD MA 01742 |
From GuruFocus
By Marketwired • 11-14-2024
By Marketwired • 05-20-2024
By Marketwired • 06-11-2024
By sperokesalga sperokesalga • 05-02-2023
By Marketwired • 09-27-2023
By Marketwired • 05-14-2024
By Marketwired • 05-30-2024
By Marketwired • 08-02-2023
By Marketwired • 10-28-2024
By Marketwired • 08-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.